Literature DB >> 21628933

Evaluation of an assessment system for the JRS 2005: A-DROP for the management of CAP in adults.

Shigeru Kohno1, Masafumi Seki, Akira Watanabe.   

Abstract

OBJECTIVE: The Japanese Respiratory Society (JRS) last revised the guidelines for community-acquired pneumonia (CAP) in adults in 2005. These guidelines proposed new criteria (A-DROP) to assess the severity of pneumonia and to differentiate between typical bacterial pneumonia and atypical pneumonia. The goal of the present study was to evaluate the utility of the A-DROP criteria for these described purposes.
METHODS: An observational survey was conducted between July 2006 and March 2007, and patients with CAP were prospectively surveyed using consecutive enrollment methods. PATIENTS: In total, 1,875 patients from 200 medical facilities throughout Japan were analyzed.
RESULTS: The JRS 2005 A-DROP system was a good indicator of mortality in the patient population, and these results were significantly correlated with the Pneumonia Severity Index (PSI) of the Infectious Disease Society of America (IDSA). Among the various factors characterized, 'SpO(2) of 90% or less (PaO(2) of 60 Torr or less)' was the strongest predictor of mortality. In terms of the differential diagnosis between typical bacterial and atypical pneumonia, five of six JRS 2005 items were strongly and significantly correlated with a diagnosis of atypical pneumonia.
CONCLUSION: The JRS 2005 A-DROP system was accurate and clinically useful for the assessment of the severity of pneumonia and for the differentiation between typical bacterial pneumonia and atypical pneumonia.

Entities:  

Mesh:

Year:  2011        PMID: 21628933     DOI: 10.2169/internalmedicine.50.4651

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  11 in total

1.  Hospital admission decision for patients with community-acquired pneumonia.

Authors:  Stefano Aliberti; Paola Faverio; Francesco Blasi
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

2.  Quantitative analysis of changes in lung density by dynamic chest radiography in association with CT values: a virtual imaging study and initial clinical corroboration.

Authors:  Teruyo Sugiura; Rie Tanaka; Ehsan Samei; William Paul Segars; Ehsan Abadi; Kazuo Kasahara; Noriyuki Ohkura; Masaya Tamura; Isao Matsumoto
Journal:  Radiol Phys Technol       Date:  2022-01-29

3.  Comparison of Pneumonia Severity Indices, qCSI, 4C-Mortality Score and qSOFA in Predicting Mortality in Hospitalized Patients with COVID-19 Pneumonia.

Authors:  Isil Kibar Akilli; Muge Bilge; Arife Uslu Guz; Ramazan Korkusuz; Esra Canbolat Unlu; Kadriye Kart Yasar
Journal:  J Pers Med       Date:  2022-05-16

4.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

5.  Development of a risk-adjusted in-hospital mortality prediction model for community-acquired pneumonia: a retrospective analysis using a Japanese administrative database.

Authors:  Hironori Uematsu; Susumu Kunisawa; Noriko Sasaki; Hiroshi Ikai; Yuichi Imanaka
Journal:  BMC Pulm Med       Date:  2014-12-16       Impact factor: 3.317

6.  Validation of a B-type natriuretic peptide as a prognostic marker in pneumonia patients: a prospective cohort study.

Authors:  Daisuke Usuda; Ryusho Sangen; Yu Hashimoto; Emiri Muranaka; Yoshitsugu Iinuma; Tsugiyasu Kanda
Journal:  BMJ Open       Date:  2016-02-23       Impact factor: 2.692

7.  Clinical factors associated with negative urinary antigen tests implemented for the diagnosis of community-acquired pneumococcal pneumonia in adult patients.

Authors:  Hidehiro Watanabe; Tomonori Uruma; Gen Tazaki; Ryota Kikuchi; Takao Tsuji; Masayuki Itoh
Journal:  Med Princ Pract       Date:  2015-01-23       Impact factor: 1.927

8.  Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan.

Authors:  Ryosuke Hirano; Masaki Fujita; Takemasa Matsumoto; Rintaro On; Kentaro Watanabe
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-23

9.  Pectoralis Muscle Mass on Chest CT at Admission Predicts Prognosis in Patients with Pneumonia.

Authors:  Ryohsuke Yokosuka; Ryosuke Imai; Shosei Ro; Manabu Murakami; Kohei Okafuji; Atsushi Kitamura; Yutaka Tomishima; Torahiko Jinta; Naoki Nishimura; Tomohide Tamura; Osamu Takahashi
Journal:  Can Respir J       Date:  2021-12-06       Impact factor: 2.409

10.  Community-acquired pneumonia caused by carbapenem-resistant Streptococcus pneumoniae: re-examining its prevention and treatment.

Authors:  Asako Doi; Kentaro Iwata; Hiroshi Takegawa; Kanji Miki; Yumi Sono; Hiroaki Nishioka; Jumpei Takeshita; Keisuke Tomii; Tsunekazu Haruta
Journal:  Int J Gen Med       Date:  2014-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.